AMPK-mediated neuromuscular plasticity: Implications for the treatment of neuromuscular disorders
AMPK-mediated neuromuscular plasticity: Implications for the treatment of neuromuscular disorders
批准号:
364110
负责人:
Ljubicic Vladimir
金额:
$7.1万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-01-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neuromuscular diseases (NMDs) represent a broad group of more than 150 genetic and acquired disorders, many of which are debilitating, progressive and cause premature death. Almost one million people in North America are believed to be affected by these d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining the molecular mechanisms of CARM1's role in the maintenance and plasticity of skeletal muscle mass and function
-
批准号:479146
-
项目类别:Operating Grants
-
资助金额:$49.88万
-
财政年份:2023
-
负责人:Ljubicic Vladimir
-
依托单位:
Canada Research Chair - Tier 2
-
批准号:404295
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2018
-
负责人:Ljubicic Vladimir
-
依托单位:
Targeting AMPK to treat muscular dystrophy
-
批准号:389362
-
项目类别:Operating Grants
-
资助金额:$36.22万
-
财政年份:2018
-
负责人:Ljubicic Vladimir
-
依托单位:
CRC Tier 2
-
批准号:314146
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2013
-
负责人:Ljubicic Vladimir
-
依托单位:
The role of the transcriptional co-repressor RIP 140 in muscular dystrophy: a therapeutic target?
-
批准号:242418
-
项目类别:Fellowship Programs
-
资助金额:$3.28万
-
财政年份:2011
-
负责人:Ljubicic Vladimir
-
依托单位:
国内基金
海外基金
Cellular & Molecular Immunology
-
批准号:30824806
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:魏海明
-
依托单位: